Interaction of mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and toll-like receptor 2

Scandinavian Journal of Immunology

Volumn 77, Issue 6, 2013, Pages 460-469

  Esin, S ^a   Counoupas, C ^a   Aulicino, A ^a   Brancatisano, F L ^a   Maisetta, G ^a   Bottai, D ^a   Di Luca, M ^a   Florio, W ^a   Campa, M ^a   Batoni, G ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOGALACTAN; BCG VACCINE; CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; MYCOLIC ACID; MYCOLYL ARABINOGALACTAN PEPTIDOGLYCAN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL WALL; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

CELL WALL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; TOLL-LIKE RECEPTOR 2;

EID: 84878165911     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12052     Document Type: Article

References (42)

1. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. What is a natural killer cell? Nat Immunol 2002;3:6-8.
2. O'Connor GM, Hart OM, Gardiner CM. Putting the natural killer cell in its place. Immunology 2005;117:1-10.
3. Kos FJ, Engleman EG. Immune regulation: a critical link between NK cells and CTLs. Immunol Today 1996;4:174-6.
4. Vankayalapati R, Klucar P, Wizel B et al. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen. J Immunol 2004;172:130-7.
5. Zhang R, Zheng X, Li B, Wei H, Tian Z. Human NK cells positively regulate gammadelta T cells in response to Mycobacterium tuberculosis. J Immunol 2006;176:2610-6.
6. Lodoen MB, Lanier LL. Natural killer cells as initial defense against pathogens. Curr Opin Immunol 2006;18:391-8.
7. Newman KC, Riley EM. Whatever turns you on: accessory cell- dependent activation of NK cells by pathogens. Nat Rev Immunol 2007;7:279-91.
8. WHO Global tuberculosis control 2011. WHO/HTM/TB/2011.16 (http://whqlibdoc.who.int/publications/2011/9789241564380_eng.pdf)
9. Brennan PJ. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2003;83:91-7.
10. Jankute M, Grover S, Rana AK, Besra GS. Arabinogalactan and lipoarabinomannan biosynthesis: structure, biogenesis and their potential as drug targets. Future Microbiol 2012;1:129-47.
11. Alsteens D, Verbelen C, Dague E, Raze D, Baulard AR, Dufrêne YF. Organization of the mycobacterial cell wall: a nanoscale view. Pflugers Arch 2008;456:117-25.
12. Culley FJ. Natural killer cells in infection and inflammation of the lung. Immunology 2009;128:151-63.
13. Marcenaro E, Ferranti B, Falco M, Moretta L, Moretta A. Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC. Int Immunol 2008;20:1155-67.
14. Vankayalapati R, Garg A, Porgador A et al. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 2005;175:4611-7.
15. Bermudez LE, Wu M, Young LS. Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium. Infect Immun 1995;63:4099-104.
16. Brill KJ, Li Q, Larkin R et al. Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms. Infect Immun 2001;69:1755-65.
17. Guerra C, Johal K, Morris D et al. Control of Mycobacterium tuberculosis growth by activated natural killer cells. Clin Exp Immunol 2012;168:142-52.
18. Denis M. Interleukin-12 (IL-12) augments cytolytic activity of natural killer cells toward Mycobacterium tuberculosis-infected human monocytes. Cell Immunol 1994;156:529-36.
19. Molloy AP, Meyn A, Smith KD, Kaplan G. Recognition and destruction of Bacillus Calmette-Guérin-infected human monocytes. J Exp Med 1993;177:1691-8.
20. Katz P, Yeager H Jr, Whalen G, Evans M, Swartz RP, Roecklein J. Natural killer cell-mediated lysis of Mycobacterium-avium complex-infected monocytes. J Clin Immunol 1990;10:71-7.
21. Roy S, Barnes PF, Garg A, Wu S, Cosman D, Vankayalapati R. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J Immunol 2008;180:1729-36.
22. Portevin D, Via LE, Eum S, Young D. Natural killer cells are recruited during pulmonary tuberculosis and their ex vivo responses to mycobacteria vary between healthy human donors in association with KIR haplotype. Cell Microbiol 2012;14:1734-44.
23. Bottino C, Castriconi R, Moretta L, Moretta A. Cellular ligands of activating NK receptors. Trends Immunol 2005;26:221-6.
24. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008;9:503-10.
25. Vitale M, Bottino C, Sivori S et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 1998;187:2065-72.
26. Arnon T I, Markel G, Mandelboim O. Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol 2006;16:348-58.
27. Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 2004;5:996-1002.
28. Chalifour A, Jeannin P, Gauchat JF et al. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood 2004;104:1778-83.
29. Athié-Morales V, O'Connor GM, Gardiner CM. Activation of human NK cells by the bacterial pathogen-associated molecular pattern muramyl dipeptide. J Immunol 2008;180:4082-9.
30. Esin S, Batoni G, Counoupas C et al. Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria. Infect Immun 2008;76:1719-27.
31. Hershkovitz O, Rosental B, Rosenberg LA et al. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol 2009;183:2610-21.
32. Esin S, Shigematsu M, Nagai S, Eklund A, Wigzell H, Grunewald J. Different percentages of peripheral blood gamma delta+ T cells in healthy individuals from different areas of the world. Scand J Immunol 1996;43:593-6.
33. Asong J, Wolfert MA, Maiti KK, Miller D, Boons G. Binding and cellular activation studies reveal that Toll-like receptor 2 can differentially recognize peptidoglycan from Gram-positive and Gram-negative bacteria. J Biol Chem 2009;284:8643-53.
34. Guan R, Mariuzza RA. Peptidoglycan recognition proteins of the innate immune system. Trends Microbiol 2010;15:127-34.
35. Cantoni C, Ponassi M, Biassoni R et al. The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity. Structure 2003;11:725-34.
36. Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 2001;31:2680-90.
37. Ho JW, Hershkovitz O, Peiris M et al. H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44. J Virol 2008;82:2028-32.
38. Hecht ML, Rosental B, Horlacher T et al. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences. J Proteome Res 2009;8:712-20.
39. Esin S, Batoni G, Källenius G et al. Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Mycobacterium avium. Clin Exp Immunol 1996;104:419-25.
40. Batoni G, Esin S, Pardini M et al. Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille Calmette Guérin. Clin Exp Immunol 2000;119:270-9.
41. Esin S, Batoni G, Pardini M et al. Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin. Immunology 2004;112:143-52.
42. dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin. Scand J Immunol 2005;62:498-506.